3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
5
Neoplasm Metastasis
3
Carcinoma, Merkel Cell
3
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Melanoma
1
Lymphatic Metastasis
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 10
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Imatinib Mesylate
4
Sunitinib
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
ripretinib
1
pemigatinib
1
Surgical Instruments
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Ipilimumab
1
IDRX-42
1
CTLA-4 Antigen
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
avelumab
×
30 days
×
Clear all
No trials found.